Your account is not claimed yet. You can sign up with ORCID to claim your account.

Michael P Lisanti

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 3

Top Topics

Oxidative Stress

Breast Cancer Cells

Epithelial Mesenchymal Transition

Top Venues

Oxidative medicine and cellular longevity

Cell death and differentiation

The FEBS journal

University of Salford

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Salford Aug 22o 2016

United Kingdom

Professor & Chair, Translational Medicine :: School of Science, Engineering and Environment (SEE)

Publications

Matteo Brindisi, Luca Frattaruolo, Marco Fiorillo, Vincenza Dolce, Federica Sotgia, Michael P Lisanti, Anna Rita Cappello
New insights into cholesterol-mediated ERRα activation in breast cancer progression and pro-tumoral microenvironment orchestration. The FEBS journal (2022)
Marco Fiorillo, Cristian Scatena, Antonio Giuseppe Naccarato, Federica Sotgia, Michael P Lisanti
Bedaquiline, an FDA-approved drug, inhibits mitochondrial ATP production and metastasis in vivo, by targeting the gamma subunit (ATP5F1C) of the ATP synthase. Cell death and differentiation 28 (9) (2021)
Stefano Falone, Michael P Lisanti, Cinzia Domenicotti
Oxidative Stress and Reprogramming of Mitochondrial Function and Dynamics as Targets to Modulate Cancer Cell Behavior and Chemoresistance. Oxidative medicine and cellular longevity 2019 (2019)